circRNAs as prognostic markers in pediatric acute myeloid leukemia
- Huiying Sun 1, Yangyang Xie 1, Xiaoyan Wu 2, Wenting Hu 1, Xiaoxiao Chen 1, Kefei Wu 1, Han Wang 1, Shuang Zhao 1, Qiaoqiao Shi 1, Xiang Wang 1, Bowen Cui 1, Wenyan Wu 1, Rongrong Fan 1, Jianan Rao 1, Ronghua Wang 1, Ying Wang 1, Ying Zhong 1, Hui Yu 2, Binbing S Zhou 1, Shuhong Shen 1, Yu Liu 3
- Huiying Sun 1, Yangyang Xie 1, Xiaoyan Wu 2
- 1Key Laboratory of Pediatric Hematology & Oncology Ministry of Health, Department of Hematology & Oncology, Pediatric Translational Medicine Institute, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- 2Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- 3Key Laboratory of Pediatric Hematology & Oncology Ministry of Health, Department of Hematology & Oncology, Pediatric Translational Medicine Institute, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; Fujian Children's Hospital, Fujian Branch of Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine, Fuzhou, China.
- 0Key Laboratory of Pediatric Hematology & Oncology Ministry of Health, Department of Hematology & Oncology, Pediatric Translational Medicine Institute, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Circular RNAs (circRNAs) impact pediatric acute myeloid leukemia (AML) prognosis. Aberrant circRNA transcription and splicing dysregulation correlate with poor outcomes, suggesting novel therapeutic targets.
Area Of Science
- Oncology
- Molecular Biology
- Genetics
Background
- Circular RNAs (circRNAs) are increasingly recognized for their roles in cancer.
- The prognostic value of circRNAs in acute myeloid leukemia (AML) is not well understood.
Purpose Of The Study
- To investigate the prognostic implications of circRNAs in pediatric AML.
- To identify circRNAs and associated molecular mechanisms linked to AML outcomes.
- To explore potential therapeutic strategies targeting aberrant circRNA expression.
Main Methods
- Genome-wide RNA sequencing (RNA-seq) analysis of circRNAs in pediatric AML patient samples.
- Correlation analysis between circRNA expression, splicing patterns, and clinical outcomes.
- Identification of RNA-binding proteins involved in circRNA biogenesis.
- Integration of drug sensitivity data to identify potential therapeutic agents.
Main Results
- A subset of circRNAs was associated with inferior clinical outcomes in pediatric AML.
- Increased circRNA and linear RNA splicing correlated significantly with poor prognosis.
- Upregulated RNA-binding proteins, including TROVE2, were linked to high circRNA numbers.
- Twenty-five drugs were identified as potential treatments for high-risk AML with aberrant circRNA transcription.
Conclusions
- CircRNAs possess significant prognostic value in pediatric AML.
- Splicing dysregulation plays a critical role in AML progression and outcomes.
- Targeting aberrant circRNA transcription offers a novel therapeutic avenue for high-risk AML.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
02:23
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
01:15
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...

